Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Obstetrics and Gynecology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Clinical gynecologic endocrinology and infertility.Lippincott Williams & Wilkins, Philadelphia2012
- An immunohistochemical study of the vascularization of the human Graafian follicle.Hum Reprod. 1994; 9: 1401-1405
- Human follicle fluid vascular endothelial growth factor concentrations are correlated with luteinization in spontaneously developing follicles.Hum Reprod. 1998; 13: 1144-1147
- The endocrinology of the menstrual cycle.Methods Mol Biol. 2014; 1154 (Chapter 7): 145-169
- Functional differentiation in steroidogenesis of two types of luteal cells isolated from mature human corpora lutea of menstrual cycle.J Clin Endocrinol Metab. 1987; 65: 1192-1200
- A differentiation antigen of human large luteal cells in corpora lutea of the menstrual cycle and early pregnancy.Biol Reprod. 1996; 54: 1173-1183
- Progesterone production by monkey luteal cell subpopulations at different stages of the menstrual cycle: changes in agonist responsiveness.Biol Reprod. 1991; 44: 141-149
- Morpho-functional study of human luteal cell subpopulations.Hum Reprod. 1994; 9: 591-596
- The rhesus monkey corpus luteum is dependent on pituitary gonadotropin secretion throughout the luteal phase of the menstrual cycle.Endocrinology. 1984; 115: 1780-1786
- Mechanisms regulating the menstrual cycle in women.Recent Prog Horm Res. 1970; 26: 63-103
- Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion.J Clin Invest. 1984; 73: 1638-1647
- Changing frequency of pulsatile luteinizing hormone and progesterone secretion during the luteal phase of the menstrual cycle of rhesus monkeys.Biol Reprod. 1984; 31: 714-722
- Normal variation in the length of the luteal phase of the menstrual cycle: identification of the short luteal phase.Br J Obstet Gynaecol. 1984; 91: 685-689
- Yen & Jaffe’s reproductive endocrinology: physiology, pathophysiology, and clinical management..Elsevier, Philadelphia2013
- Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle.J Clin Endocrinol Metab. 1986; 62: 1136-1144
- The surplus human embryo: its potential for growth, blastulation, hatching, and human chorionic gonadotropin production in culture.Fertil Steril. 1989; 51: 984-991
- The significance of the human corpus luteum in pregnancy maintenance.Am J Obstet Gynecol. 1972; 112: 1061-1067
- Effects of luteectomy and progesterone replacement therapy in early pregnant patients.Am J Obstet Gynecol. 1973; 115: 759-765
- The clinical relevance of luteal phase deficiency: a committee opinion.Fertil Steril. 2012; 98: 1112-1117
- Some newer aspects of the management of infertility.JAMA. 1949; 141: 1123-1129
- Luteal phase defect.Curr Opin Obstet Gynecol. 1991; 3: 641-648
- An integrated view on the luteal phase: diagnosis and treatment in subfertility.Clin Endocrinol (Oxf). 2012; 77: 500-507
- Luteal phase deficiency in regularly menstruating women: prevalence and overlap in identification based on clinical and biochemical diagnostic criteria.J Clin Endocrinol Metab. 2014; 99: E1007-E1014
- Superovulation of habitual aborters with subtle luteal phase deficiency.Int J Fertil. 1987; 32: 359-365
- The inadequate luteal phase.Am J Obstet Gynecol. 1962; 83: 363-372
- Unexplained infertility: evaluation of the luteal phase; results of the National Center for Infertility Research at Michigan.Fertil Steril. 1997; 67: 437-442
- Progesterone implantation in habitual abortion.Br Med J. 1953; 1: 1073-1077
- Endocrinology and recurrent early pregnancy loss.Semin Reprod Med. 2011; 29: 482-490
- The short luteal phase and infertility.Br J Obstet Gynaecol. 1984; 91: 1120-1122
- The short luteal phase.Obstet Gynecol Surv. 1970; 25: 775-777
- Luteal phase defect: the sensitivity and specificity of diagnostic methods in common clinical use.Fertil Steril. 1994; 62: 54-62
- Luteal progesterone relates to histological endometrial maturation in fertile women.J Clin Endocrinol Metab. 2000; 85: 4207-4211
- Dating the endometrial biopsy.Am J Obstet Gynecol. 1975; 122: 262-263
- Endometrial biopsy in the evaluation of infertility.Fertil Steril. 1980; 33: 121-124
- A critical analysis of the accuracy, reproducibility, and clinical utility of histologic endometrial dating in fertile women.Fertil Steril. 2004; 81: 1333-1343
- Histological dating of timed endometrial biopsy tissue is not related to fertility status.Fertil Steril. 2004; 82: 1264-1272
- Progesterone function in human endometrium: clinical perspectives.Semin Reprod Med. 2010; 28: 5-16
- Common pathophysiological mechanisms involved in luteal phase deficiency and polycystic ovary syndrome. Impact on fertility.Endocrine. 2013; 43: 314-317
- Endometrial development and function in experimentally induced luteal phase deficiency.J Clin Endocrinol Metab. 2008; 93: 4058-4064
- Sporadic and recurrent luteal phase defects in cyclic women: comparison with normal cycles.Fertil Steril. 1980; 33: 372-377
- Plasma gonadotropin and sex steroid hormone levels during early, midfollicular, and midluteal phases of women with luteal phase defects.Fertil Steril. 1983; 40: 45-48
- Luteal phase deficiency after completely normal follicular and periovulatory phases.Fertil Steril. 1989; 52: 919-923
- Luteal phase deficiency: abnormal gonadotropin and progesterone secretion patterns.J Clin Endocrinol Metab. 1989; 69: 813-820
- Luteal phase deficiency: pathophysiology, diagnosis, and treatment.in: Gynecology and obstetrics, vol. 5. Global Libr Women's Med. David G.T. Bloomer, London2009
- Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol.Hum Reprod. 1992; 7: 1225-1229
- Efficacy of clomiphene citrate in the treatment of luteal phase deficiency: quantity versus quality of preovulatory follicles.Fertil Steril. 1990; 54: 206-210
- Use of human menopausal gonadotropins in the treatment of endometrial defects associated with recurrent miscarriage: preliminary report.Fertil Steril. 2001; 75: 434-437
- The effect of Provera on the fetus.Obstet Gynecol. 1964; 23: 931
- Teratogenicity of progestogens given during the first trimester of pregnancy.Obstet Gynecol Surv. 1985; 40: 697-698
- Oral clomiphene citrate and vaginal progesterone suppositories in the treatment of luteal phase dysfunction: a comparative study.Fertil Steril. 1989; 51: 35-41
- Efficacy of progesterone support for pregnancy in women with recurrent miscarriage. A meta-analysis of controlled trials.Br J Obstet Gynaecol. 1989; 96: 275-280
- Establishing full-term human pregnancies using cleaving embryos grown in vitro.Br J Obstet Gynaecol. 1980; 87: 737-756
- Luteal phase support for assisted reproduction cycles.Cochrane Database Syst Rev. 2011; (CD009154)
- Human luteal phase function following oocyte aspiration from the immediately preovular graafian follicle of spontaneous ovular cycles.Br J Obstet Gynaecol. 1981; 88: 1021-1028
- Suppression of serum levels of luteinizing hormone by short- and long-loop negative feedback in ovariectomized women.J Endocrinol. 1979; 80: 353-356
- Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.J Clin Endocrinol Metab. 2003; 88: 4186-4192
- Reproductive biology and IVF: ovarian stimulation and luteal phase consequences.Trends Endocrinol Metab. 2003; 14: 236-242
- The luteal phase after 3 decades of IVF: what do we know?.Reprod Biomed Online. 2009; 19: 1-13
- Luteal-phase support in assisted reproduction treatment: real-life practices reported worldwide by an updated website-based survey.Reprod Biomed Online. 2014; 28: 330-335
- Progesterone support in IVF: is evidence-based medicine translated to clinical practice? A worldwide web-based survey.Reprod Biomed Online. 2012; 25: 139-145
- Luteal phase support in assisted reproduction cycles.Cochrane Database Syst Rev. 2004; 3: CD004830
- Progesterone supplementation during the luteal phase and in early pregnancy in the treatment of infertility: an educational bulletin.Fertil Steril. 2008; 90: S150-S153
- The absorption of oral micronized progesterone: the effect of food, dose proportionality, and comparison with intramuscular progesterone.Fertil Steril. 1993; 60: 26-33
- Bioavailability of oral micronized progesterone.Fertil Steril. 1985; 44: 622-626
- Oral versus intramuscular progesterone for in vitro fertilization: a prospective randomized study.Fertil Steril. 1999; 71: 614-618
- Luteal support with micronized progesterone following in-vitro fertilization using a down-regulation protocol with gonadotrophin-releasing hormone agonist: a comparative study between vaginal and oral administration.Hum Reprod. 1999; 14: 1944-1948
- Use of dydrogesterone as a progestogen for oral contraception.Steroids. 2003; 68: 927-929
- Modulating fertility outcome in assisted reproductive technologies by the use of dydrogesterone.Gynecol Endocrinol. 2007; 23: 68-72
- Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles: results of a randomised study.J Steroid Biochem Mol Biol. 2005; 97: 416-420
- Comparison of oral dydrogestrone with progesterone gel and micronized progesterone for luteal support in 1,373 women undergoing in vitro fertilization: a randomized clinical study.Fertil Steril. 2011; 95: 1961-1965
- Oral progestogen versus intramuscular progesterone for luteal support after assisted reproductive technology treatment: a prospective randomized study.Arch Gynecol Obstet. 2008; 277: 319-324
- Support of the luteal phase in in vitro fertilization programs: results of a controlled trial with intramuscular Proluton.J In Vitro Fert Embryo Transf. 1985; 2: 166-169
- A randomized study comparing Crinone 8% and intramuscular progesterone supplementation in in vitro fertilization-embryo transfer cycles.Fertil Steril. 2001; 76: 1144-1149
- Intramuscular versus vaginal progesterone in assisted reproduction: a comparative study.Clin Exp Obstet Gynecol. 1997; 24: 228-231
- A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone.Fertil Steril. 2009; 92: 163-169
- Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study.Fertil Steril. 1994; 62: 485-490
- Investigation of product quality between extemporaneously compounded progesterone vaginal suppositories and an approved progesterone vaginal gel.Drug Dev Ind Pharm. 2004; 30: 1069-1078
- Endometrin for luteal phase support in a randomized, controlled, open-label, prospective in-vitro fertilization trial using a combination of Menopur and Bravelle for controlled ovarian hyperstimulation.Fertil Steril. 2009; 91: 1012-1017
- Water soluble progesterone–hydroxypropyl-β-cyclodextrin complex for injectable formulations.J Incl Phenom Macrocycl Chem. 2007; 57: 283-288
- Pharmacokinetics and safety profile of a novel progesterone aqueous formulation administered by the s.c. route.Gynecol Endocrinol. 2013; 29: 205-208
- Subcutaneous progesterone versus vaginal progesterone gel for luteal phase support in in vitro fertilization: a noninferiority randomized controlled study.Fertil Steril. 2014; 101: 112-119.e3
- A randomized, controlled trial comparing the efficacy and safety of aqueous subcutaneous progesterone with vaginal progesterone for luteal phase support of in vitro fertilization.Hum Reprod. 2014; 29: 2212-2220
- Effects of vaginal progesterone administration starting on the day of oocyte retrieval on pregnancy rates.J Assist Reprod Genet. 2003; 20: 517-520
- Timing luteal phase support in GnRH agonist down-regulated IVF/embryo transfer cycles.Hum Reprod. 2006; 21: 905-908
- The window for embryo transfer in oocyte donation cycles depends on the duration of progesterone therapy.Hum Reprod. 1998; 13: 720-723
- The optimal duration of progesterone supplementation in pregnant women after IVF/ICSI: a meta-analysis.Reprod Biol Endocrinol. 2012; 10: 107
- An update of luteal phase support in stimulated IVF cycles.Hum Reprod Update. 2007; 13: 581-590
- Estrogen addition to progesterone for luteal phase support in cycles stimulated with GnRH analogues and gonadotrophins for IVF: a systematic review and meta-analysis.Hum Reprod. 2008; 23: 1346-1354
- GnRH agonist as novel luteal support: results of a randomized, parallel group, feasibility study using intranasal administration of buserelin.Hum Reprod. 2005; 20: 1798-1804
- Administration of single-dose GnRH agonist in the luteal phase in ICSI cycles: a meta-analysis.Reprod Biol Endocrinol. 2010; 8: 107
- Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles.Hum Reprod. 2006; 21: 2572-2579
- GnRH agonist protocol administration in the luteal phase in ICSI-ET cycles stimulated with the long GnRH agonist protocol: a randomized, controlled double blind study.Hum Reprod. 2008; 23: 668-673
- Single-dose GnRH agonist administration in the luteal phase of GnRH antagonist cycles: a prospective randomized study.Reprod Biomed Online. 2009; 19: 472-477
- Beneficial effect of luteal-phase gonadotropin-releasing hormone agonist administration on implantation rate after intracytoplasmic sperm injection.Taiwan J Obstet Gynecol. 2009; 48: 245-248
- Single dose GnRH agonist administration in the luteal phase of assisted reproduction cycles: is the effect dependent on the type of GnRH analogue used for pituitary suppression?.Reprod Biomed Online. 2010; 20: 165-166
- Luteal phase support for frozen embryo transfer cycles: intramuscular or vaginal progesterone?.Fertil Steril. 2014; 101: 627-628
- Experience with a novel vaginal progesterone preparation in a donor oocyte program.Fertil Steril. 1998; 69: 96-101
- Crinone 8% (90 mg) given once daily for progesterone replacement therapy in donor egg cycles.Fertil Steril. 1999; 72: 980-984
- Pregnancy outcomes in oocyte donation recipients: vaginal gel versus intramuscular injection progesterone replacement.J Assist Reprod Genet. 2012; 29: 237-242
- Progesterone replacement with vaginal gel versus i.m. injection: cycle and pregnancy outcomes in IVF patients receiving vitrified blastocysts.Hum Reprod. 2014; 29: 1706-1711
- Intramuscular progesterone versus 8% Crinone vaginal gel for luteal phase support for day 3 cryopreserved embryo transfer.Fertil Steril. 2012; 98: 1464-1469
- Intramuscular route of progesterone administration increases pregnancy rates during non-downregulated frozen embryo transfer cycles.J Assist Reprod Genet. 2007; 24: 467-470
- What is the “ideal” duration of progesterone supplementation before the transfer of cryopreserved-thawed embryos in estrogen/progesterone replacement protocols?.Hum Reprod. 2005; 20: 1127-1134
Article info
Publication history
Published online: January 05, 2015
Footnotes
The authors have nothing to disclose.
Identification
Copyright
© 2015 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
